“…The first reported case in an immunocompetent host occurred in Jacksonville, Florida in 2014 involving the lung and lymph node [ 14 ]. This was followed by additional reports of pulmonary Nocardiosis [ [15] , [16] , [17] , [18] ] and one case of scleritis in immunocompetent hosts [ 19 ]. The first case reports of CNS involvement in immunocompetent patients were reported in 2019 and again in 2020 [ [20] , [21] , [22] , [23] , [24] ].…”